See what we’re reading this week at Global Biodefense on topics including disaster preparedness, China’s Ebola drug, nerve agent treatments and more…
WHO calls emergency meeting on complex South Korea MERS outbreak (Reuters)
Finding better treatments for nerve agents (Battelle)
A Chinese Ebola Drug raises hopes, and rancor (NY Times)
Upping our game for disaster preparedness and response (White House OSTP)
Stealth attack: infection and disease on the battlefield (The Conversation)
Lawmakers ask whether Homeland Security fumbled in fighting bioterror (WP)
Research chimps to be listed as ‘endangered’ (Science)
MERS virus’s path: One man, many South Korean hospitals (NY Times)
Anthrax: Department of Defense laboratory review (DoD)
As MERS outbreak surges, genetic tests show virus hasn’t mutated (NPR)
G7 states vow to wipe out Ebola but offer little concrete action (Reuters)
Anthrax scare: Remain calm, all is well (War on the Rocks)
CDC says its investigation into listeria outbreak is over (Food Safety News)
Ultrasensitive nanomechanical biosensor developed (MDT)
Boldly going where no vaccine has gone before (Tracking Zebra)
Microsoft is using drones to predict disease outbreaks (Nextgov)
Accidental anthrax shipments follow a familiar pattern (LA Times)
The devil you know vs. the devil you fear (The Bifurcated Needle)
Most recent Ebola papers (PubMed)
MERS outbreak in Korea may be past its peak, panel says (Science)
West African travel-related illnesses: Not just Ebola (UPMC CBN)
Ebola could hit again and we would hardly do better: MSF (Reuters)
